Cancer statistics have reached new heights — in good and not-so-good ways. The American Cancer Society (ACS) released its annual report on cancer trends this week, showing for the first time that more ...

The MarketWatch News Department was not involved in the creation of this content. Neuroendocrine Carcinoma Market Poised for Significant Growth During the Forecast Period (2026-2036) Driven by Rising ...

For the first time ever, the five-year survival rate for all cancers combined has reached 70 percent. While it’s a moment to celebrate, doctors warn the fight is far from over. Sean Stevenson ...

People who have received a cancer diagnosis are living longer than ever, according to a new report from the American Cancer Society (ACS). Decades of cancer research have led to more effective ...

People are living longer after a cancer diagnosis than ever before. According to a new report from the American Cancer Society (ACS), 70% of those who receive a cancer diagnosis survive for five or ...

This is read by an automated voice. Please report any issues or inconsistencies here. The American Cancer Society’s 2026 Cancer Statistics report, released Tuesday, marks a major milestone for U.S.

The neuroendocrine carcinoma market is experiencing steady growth driven by rising disease prevalence and improved diagnostic capabilities. Advancements in targeted therapies and immunotherapies ...